Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats
- 29 February 2012
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 677 (1-3) , 180-187
- https://doi.org/10.1016/j.ejphar.2011.12.003
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complicationsEuropean Journal of Pharmacology, 2011
- Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic ratsEuropean Journal of Pharmacology, 2011
- Diet‐induced obesity in Sprague–Dawley rats causes microvascular and neural dysfunctionDiabetes/Metabolism Research and Reviews, 2010
- Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Diabetologia, 2010
- Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent ObesityDiabetes, 2009
- Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleusBiochemical and Biophysical Research Communications, 2009
- Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionDiabetes, Obesity and Metabolism, 2009
- Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688Experimental Diabetes Research, 2009
- Epidermal nerve fiber quantification in the assessment of diabetic neuropathyActa Histochemica, 2008
- Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screeningPharmacological Research, 2005